MA54074A - Compositions comprenant des souches bactériennes - Google Patents
Compositions comprenant des souches bactériennesInfo
- Publication number
- MA54074A MA54074A MA054074A MA54074A MA54074A MA 54074 A MA54074 A MA 54074A MA 054074 A MA054074 A MA 054074A MA 54074 A MA54074 A MA 54074A MA 54074 A MA54074 A MA 54074A
- Authority
- MA
- Morocco
- Prior art keywords
- compositions
- bacterial strains
- strains
- bacterial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18204199 | 2018-11-02 | ||
| GBGB1820261.4A GB201820261D0 (en) | 2018-12-12 | 2018-12-12 | Compositions comprising bacterial strains |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA54074A true MA54074A (fr) | 2022-02-09 |
Family
ID=68610160
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA054074A MA54074A (fr) | 2018-11-02 | 2019-11-04 | Compositions comprenant des souches bactériennes |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210393773A1 (fr) |
| EP (1) | EP3873518A1 (fr) |
| JP (1) | JP2022512813A (fr) |
| KR (1) | KR20210088585A (fr) |
| CN (1) | CN114025794A (fr) |
| AU (1) | AU2019373731A1 (fr) |
| CA (1) | CA3117865A1 (fr) |
| IL (1) | IL282439A (fr) |
| MA (1) | MA54074A (fr) |
| SG (1) | SG11202104258TA (fr) |
| TW (1) | TW202034949A (fr) |
| WO (1) | WO2020089488A1 (fr) |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5700787A (en) * | 1994-09-02 | 1997-12-23 | Brigham & Women's Hospital, Inc. | Capsular polysaccharide immunomodulator |
| GB0127916D0 (en) | 2001-11-21 | 2002-01-16 | Rowett Res Inst | Method |
| GB0526033D0 (en) * | 2005-12-21 | 2006-02-01 | Bioeos Ltd | Method |
| GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
| GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
| GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
| MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| WO2016149449A1 (fr) * | 2015-03-18 | 2016-09-22 | Tufts University | Compositions et méthodes pour le traitement du cancer colorectal |
| MA41060B1 (fr) * | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
| CA3016911A1 (fr) * | 2016-03-14 | 2017-09-21 | Holobiome, Inc. | Modulation du microbiome intestinal pour traiter les troubles mentaux ou les maladies du systeme nerveux central |
| IL296740B2 (en) * | 2016-12-23 | 2023-09-01 | Univ Keio | Compositions and methods for the induction of cd8+ t-cells |
| KR20180107341A (ko) * | 2017-03-16 | 2018-10-02 | 차의과학대학교 산학협력단 | 칼륨 경쟁적 위산분비억제제를 유효성분을 함유하는 장 누수 증후군 치료 및 예방용 조성물 |
| SG11202106258YA (en) * | 2018-12-12 | 2021-07-29 | 4D Pharma Res Ltd | Compositions comprising parabacteroides bacterial strains for treating cancer |
-
2019
- 2019-11-04 CN CN201980072246.0A patent/CN114025794A/zh active Pending
- 2019-11-04 KR KR1020217014421A patent/KR20210088585A/ko not_active Ceased
- 2019-11-04 SG SG11202104258TA patent/SG11202104258TA/en unknown
- 2019-11-04 WO PCT/EP2019/080131 patent/WO2020089488A1/fr not_active Ceased
- 2019-11-04 CA CA3117865A patent/CA3117865A1/fr active Pending
- 2019-11-04 JP JP2021522499A patent/JP2022512813A/ja active Pending
- 2019-11-04 TW TW108139911A patent/TW202034949A/zh unknown
- 2019-11-04 AU AU2019373731A patent/AU2019373731A1/en not_active Abandoned
- 2019-11-04 MA MA054074A patent/MA54074A/fr unknown
- 2019-11-04 EP EP19805547.7A patent/EP3873518A1/fr active Pending
-
2021
- 2021-04-19 IL IL282439A patent/IL282439A/en unknown
- 2021-04-30 US US17/245,060 patent/US20210393773A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20210088585A (ko) | 2021-07-14 |
| AU2019373731A1 (en) | 2021-05-27 |
| EP3873518A1 (fr) | 2021-09-08 |
| US20210393773A1 (en) | 2021-12-23 |
| IL282439A (en) | 2021-06-30 |
| WO2020089488A1 (fr) | 2020-05-07 |
| TW202034949A (zh) | 2020-10-01 |
| JP2022512813A (ja) | 2022-02-07 |
| SG11202104258TA (en) | 2021-05-28 |
| CN114025794A (zh) | 2022-02-08 |
| CA3117865A1 (fr) | 2020-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA49425A (fr) | Compositions comprenant des souches bactériennes | |
| MA41708A (fr) | Compositions comprenant des souches bactériennes | |
| MA42351A (fr) | Compositions comprenant des souches bactériennes | |
| MA40754A (fr) | Compositions comprenant des souches bactériennes | |
| MA45287A (fr) | Compositions comprenant des souches bactériennes | |
| MA52860A (fr) | Compositions comprenant des souches bactériennes | |
| SMT202200217T1 (it) | Composizioni comprendenti ceppi batterici | |
| MA51455A (fr) | Compositions comprenant des souches bactériennes | |
| MA51639A (fr) | Compositions comprenant des souches bactériennes | |
| MA52128A (fr) | Compositions comprenant des souches bactériennes | |
| MA48941A (fr) | Compositions comprenant des souches bactériennes | |
| DK3600363T3 (da) | Sammensætninger omfattende bakteriestammer | |
| LT3638271T (lt) | Kompozicijos, apimančios bakterines padermes | |
| MA49982A (fr) | Compositions comprenant des souches bactériennes | |
| MA53155A (fr) | Compositions comprenant des souches bactériennes | |
| MA53860A (fr) | Compositions comprenant des souches bactériennes | |
| MA53228A (fr) | Compositions comprenant des souches bactériennes | |
| LT3723777T (lt) | Kompozicijos, apimančios bakterines padermes | |
| MA54074A (fr) | Compositions comprenant des souches bactériennes | |
| MA51709A (fr) | Compositions comprenant des souches bactériennes | |
| MA49322A (fr) | Compositions comprenant des souches bactériennes | |
| GB201820744D0 (en) | Compositions comprising bacterial strains | |
| GB201820745D0 (en) | Compositions comprising bacterial strains | |
| GB201820261D0 (en) | Compositions comprising bacterial strains | |
| GB201820264D0 (en) | Compositions comprising bacterial strains |